Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

OncoGenex Pharmaceuticals Company Profile (NASDAQ:OGXI)

Consensus Ratings for OncoGenex Pharmaceuticals (NASDAQ:OGXI) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $5.50 (159.43% upside)

Analysts' Ratings History for OncoGenex Pharmaceuticals (NASDAQ:OGXI)
Show:
DateFirmActionRatingPrice TargetActions
3/30/2015Needham & Company LLCLower Price TargetBuy$14.00 -> $7.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/30/2014William BlairSet Price TargetBuy$8.00 -> $4.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/19/2014Needham & Company LLCSet Price TargetBuy$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/29/2014Stifel NicolausLower Price TargetBuy$21.00 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/29/2014RBC CapitalDowngradeOutperform -> Sector Perform$19.00 -> $4.50View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/28/2014Needham & Company LLCDowngradeStrong-Buy -> Buy$30.00 -> $14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/27/2014CRT CapitalInitiated CoverageBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/8/2013Stifel NicolausLower Price TargetBuy$26.00 -> $21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/28/2013Needham & Company LLCUpgradeBuy -> Strong-Buy$20.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/9/2013Stifel NicolausLower Price TargetBuy$30.00 -> $26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 5/30/2013 forward)